Nirwan J.S., Hasan S.S., Babar Z.-U.-D., Conway B.R., Ghori M.U. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. Sci Rep. 2020;10(1):5814. Available at: https://pubmed.ncbi.nlm.nih.gov/32242117/.https://pubmed.ncbi.nlm.nih.gov/32242117/
Nirwan J.S., Hasan S.S., Babar Z.-U.-D., Conway B.R., Ghori M.U. Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis. Sci Rep. 2020;10(1):5814. Available at: https://pubmed.ncbi.nlm.nih.gov/32242117/.https://pubmed.ncbi.nlm.nih.gov/32242117/
GBD 2017 Gastro-oesophageal Reflux Disease Collaborators. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5(6):561–581. https://doi.org/10.1016/S2468-1253(19)30408-X..
DOI: 10.1016/S2468-1253(19)30408-X
Ивашкин В.Т., Маев И.В., Трухманов А.С., Лапина Т.Л., Сторонова О.А., Зайратьянц О.В. и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению гастроэзофагеальной рефлюксной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020;30(4):70–97. https://doi.org/10.22416/1382-4376-2020-30-4-70-97..
DOI: 10.22416/1382-4376-2020-30-4-70-97
Drossman D.A. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262–1279. https://doi.org/10.1053/j.gastro.2016.02.032..
DOI: 10.1053/j.gastro.2016.02.032
Vakil N., van Zanten S.V., Kahrilas P., Dent J., Jones R., Global Consensus Group The Montreal. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–1920. https://doi.org/10.1111/j.1572-0241.2006.00630.x..
DOI: 10.1111/j.1572-0241.2006.00630.x
Лазебник Л.Б., Машарова А.А., Бордин Д.С., Васильев Ю.В., Ткаченко Е.И., Абдулхаков Р.А. и др. Результаты Многоцентрового исследования «Эпидемиология Гастроэзофагеальной Рефлюксной Болезни в России» (МЭГРЕ). Терапевтический архив. 2011;83(1):45–50. Режим доступа: https://ter-arkhiv.ru/0040-3660/article/view/30789.https://ter-arkhiv.ru/0040-3660/article/view/30789
Лазебник Л.Б., Машарова А.А., Бордин Д.С., Васильев Ю.В., Ткаченко Е.И., Абдулхаков Р.А. и др. Результаты Многоцентрового исследования «Эпидемиология Гастроэзофагеальной Рефлюксной Болезни в России» (МЭГРЕ). Терапевтический архив. 2011;83(1):45–50. Режим доступа: https://ter-arkhiv.ru/0040-3660/article/view/30789.https://ter-arkhiv.ru/0040-3660/article/view/30789
Eusebi L.H., Ratnakumaran R., Yuan Y., Solaymani-Dodaran M., Bazzoli F., Ford A.C. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67(3):430–440. https://doi.org/10.1136/gutjnl-2016-313589..
DOI: 10.1136/gutjnl-2016-313589
Chatila A.T., Nguyen M.T.T., Krill T., Roark R., Bilal M., Reep G. Natural history, pathophysiology and evaluation of gastroesophageal reflux disease. Dis Mon. 2020;66(1):100848. https://doi.org/10.1016/j.disamonth.2019.02.001..
DOI: 10.1016/j.disamonth.2019.02.001
Zhang M., Hou Z.-K., Huang Z.-B., Chen X.-L., Liu F.-B. Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review. Ther Clin Risk Manag. 2021;17:305–323. https://doi.org/10.2147/TCRM.S296680..
DOI: 10.2147/TCRM.S296680
Argyrou A., Legaki E., Koutserimpas C., Gazouli M., Papaconstantinou J., Gkiokas G., Karamanolis G. Risk factors for gastroesophageal reflux disease and analysis of genetic contributors. World J Clin Cases . 2018;6(8):176–182. https://doi.org/10.12998/wjcc.v6.i8.176..
DOI: 10.12998/wjcc.v6.i8.176
Zheng Z., Nordenstedt H., Pedersen N.L., Lagergren J., Ye W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology. 2007;132(1):87–95. https://doi.org/10.1053/j.gastro.2006.11.019..
DOI: 10.1053/j.gastro.2006.11.019
Kahrilas P.J., Gupta R.R. Mechanisms of acid reflux associated with cigarette smoking. Gut. 1990;31(1):4–10. https://doi.org/10.1136/gut.31.1.4..
DOI: 10.1136/gut.31.1.4
Андреев Д.Н., Кучерявый Ю.А. Ожирение как фактор риска заболеваний пищеварительной системы. Терапевтический архив. 2021;93(8):954–962. https://doi.org/10.26442/00403660.2021.08.200983..
DOI: 10.26442/00403660.2021.08.200983
Murray L., Johnston B., Lane A., Harvey I., Donovan J., Nair P., Harvey R. Relationship between body mass index and gastro-esophageal reflux symptoms: The Bristol helicobacter project. Int J Epidemiol. 2003;32(4):645–650. https://doi.org/10.1093/ije/dyg108..
DOI: 10.1093/ije/dyg108
Jacobson B.C., Somers S.C., Fuchs C.S., Kelly C.P., Carlos A.C.Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354(22):2340–2348. https://doi.org/10.1056/NEJMoa054391..
DOI: 10.1056/NEJMoa054391
Mathus-Vliegen E.M.H., Tygat G.N.J. Gastro-oesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol. 2002;37(11):1246–1252. https://doi.org/10.1080/003655202761020498..
DOI: 10.1080/003655202761020498
Mathus-Vliegen E.M.H., van Weeren M., van Eerten P.V. Los function and obesity: the impact of untreated obesity, weight loss, and chronic gastric balloon distension. Digestion. 2003;68(2–3):161–168. https://doi.org/10.1159/000075525..
DOI: 10.1159/000075525
Singh M., Lee J., Gupta N., Gaddam S., Smith B.K., Wani S.B. et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring). 2013;21(2):284–290. https://doi.org/10.1002/oby.20279..
DOI: 10.1002/oby.20279
Schneider J.H., Kuper M., Konigsrainer A., Brücher B. Transient lower esophageal sphincter relaxation in morbid obesity. Obes Surg. 2009;19(5):595–600. https://doi.org/10.1007/s11695-009-9809-7..
DOI: 10.1007/s11695-009-9809-7
Cote-Daigneault J., Leclerc P., Joubert J., Bouin M. High prevalence of esophageal dysmotility in asymptomatic obese patients. Can J Gastroenterol Hepatol. 2014;28(6):311–314. https://doi.org/10.1155/2014/960520..
DOI: 10.1155/2014/960520
de Mello Del Grande L., Herbella F.A.M., Katayama R.C., Lima W.G., Patti M.G. Transdiaphragmatic Pressure Gradient (TPG) Has a Central Role in the Pathophysiology of Gastroesophageal Reflux Disease (GERD) in the Obese and it Correlates with Abdominal Circumference but Not with Body Mass Index (BMI). Obes Surg. 2020;30(4):1424–1428. https://doi.org/10.1007/s11695-019-04345-x..
DOI: 10.1007/s11695-019-04345-x
Cameron A.J., Lagergren J., Henriksson C., Nyren O., Locke 3rd G.R., Pedersen N.L. Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology. 2002;122(1):55–59. https://doi.org/10.1053/gast.2002.30301..
DOI: 10.1053/gast.2002.30301
Mohammed I., Cherkas L.F., Riley S.A., Spector T.D., Trudgill N.J. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut. 2003;52(8):1085–1089. https://doi.org/10.1136/gut.52.8.1085..
DOI: 10.1136/gut.52.8.1085
Ghoshal U.C., Chourasia D. Genetic factors in the pathogenesis of gastro-esophageal reflux disease. Indian J Gastroenterol. 2011;30(2):55–62. https://doi.org/10.1007/s12664-011-0095-7..
DOI: 10.1007/s12664-011-0095-7
Bonfiglio F., Hysi P.G., Ek W., Karhunen V., Rivera N.V., Männikkö M. et al. A meta-analysis of reflux genome-wide association studies in 6750 Northern Europeans from the general population. Neurogastroenterol Motil. 2017;29(2). https://doi.org/10.1111/nmo.12923..
DOI: 10.1111/nmo.12923
Mungan Z., Şimşek B.P. Which drugs are risk factors for the development of gastroesophageal reflux disease? Turk J Gastroenterol. 2017;28(Suppl 1): S38–S43. https://doi.org/10.5152/tjg.2017.11..
DOI: 10.5152/tjg.2017.11
Valezi A.C., Herbella F.A.M., Schlottmann F., Patti M.G. Gastroesophageal reflux disease in obese patients. J Laparoendosc Adv Surg Tech A. 2018;28(8):949–952. https://doi.org/10.1089/lap.2018.0395..
DOI: 10.1089/lap.2018.0395
Fox M., Barr C., Nolan S., Lomer M., Anggiansah A., Wong T. The effects of dietary fat and calorie density on esophageal acid exposure and reflux symptoms. Clin Gastroenterol Hepatol. 2007;5(4):439–444. https://doi.org/10.1016/j.cgh.2006.12.013..
DOI: 10.1016/j.cgh.2006.12.013
Hirsch D.P., Mathus-Vliegen E.M., Holloway R.H., Fakhry N., D’Amato M., Boeck xstaens G.E.E. Role of CCK(A) receptors in postprandial lower esophageal sphincter function in morbidly obese subjects. Dig Dis Sci. 2002;47(11):2531–2537. https://doi.org/10.1023/a:1020520311938..
DOI: 10.1023/a:1020520311938
Ahmed S., Jamil S., Shaikh H., Abbasi M. Effects of life style factors on the symptoms of gastro esophageal reflux disease: a cross sectional study in a Pakistani population. Pak J Med Sci. 2020;36(2):115–120. https://doi.org/10.12669/pjms.36.2.1371..
DOI: 10.12669/pjms.36.2.1371
Fujiwara Y., Machida A., Watanabe Y., Shiba M., Tominaga K., Watanabe T., Oshitani N. et al. Association between dinner-to-bed time and gastro-esophageal reflux disease. Am J Gastroenterol. 2005;100(12):2633–2636. https://doi.org/10.1111/j.1572-0241.2005.00354.x..
DOI: 10.1111/j.1572-0241.2005.00354.x
Xiaodan L., Zhuoqin J., Niandi T. Correlation between lifestyle and dietary habit and gastroesophageal reflux disease. New Med. 2018;49(1):52–56.
Andrici J., Cox M.R., Eslick G.D. Cigarette smoking and the risk of Barrett’s esophagus: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2013;28(8):1258–1273. https://doi.org/10.1111/jgh.12230..
DOI: 10.1111/jgh.12230
Pan J., Cen L., Chen W., Yu C., Li Y., Shen Z. Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta-analysis. Alcohol Alcohol. 2019;54(1):62–69. https://doi.org/10.1093/alcalc/agy063..
DOI: 10.1093/alcalc/agy063
Fass R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J Clin Gastroenterol. 2007;41(2):131–137. https://doi.org/10.1097/01.mcg.0000225631.07039.6d..
DOI: 10.1097/01.mcg.0000225631.07039.6d
Wong W.M., Lai K.C., Hui W.M., Hu W.H.C., Huang J.Q., Wong N.Y. et al. Pathophysiology of gastroesophageal reflux diseases in Chinese – role of transient lower esophageal sphincter relaxation and esophageal motor dysfunction. Am J Gastroenterol. 2004;99(11):2088–2093. https://doi.org/10.1111/j.1572-0241.2004.30417.x..
DOI: 10.1111/j.1572-0241.2004.30417.x
Barlow W.J., Orlando R.C. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology. 2005;128(3):771–778. https://doi.org/10.1053/j.gastro.2004.08.014..
DOI: 10.1053/j.gastro.2004.08.014
Surdea-Blaga T., Negrutiu D.E., Palage M., Dumitrascu D.L. Food and Gastroesophageal Reflux Disease. Curr Med Chem. 2019;26(19):3497–3511. https://doi.org/10.2174/0929867324666170515123807..
DOI: 10.2174/0929867324666170515123807
Yi W., Shengliang Z. Related risk factors of non-erosive reflux disease. IntJ Digestive Dis. 2018;38(1):32–36.
Hongliang G., Wentao F., Ping Y. Analysis of Risk Factors for Gastroesophageal Reflux Disease. Chin J Gastroenterol. 2012;17(8):483–487. https://doi.org/10.3969/j.issn.1008-7125.2012.08.009..
DOI: 10.3969/j.issn.1008-7125.2012.08.009
Milke P., Diaz A., Valdovinos M.A., Moran S. Gastroesophageal reflux in healthy subjects induced by two different species of chilli (Capsicum annum). Dig Dis. 2006;24(1–2):184–188. https://doi.org/10.1159/000090323..
DOI: 10.1159/000090323
Shay S.S., Johnson L.F. Upright refluxers without esophagitis differentiated from bipositional refluxers with esophagitis by simultaneous manometry and pH monitoring conducted in two postures before and after a meal. Am J Gastroenterol. 1994;89(7):992–1002. Available at: https://pubmed.ncbi.nlm.nih.gov/8017397/.https://pubmed.ncbi.nlm.nih.gov/8017397/
Shay S.S., Johnson L.F. Upright refluxers without esophagitis differentiated from bipositional refluxers with esophagitis by simultaneous manometry and pH monitoring conducted in two postures before and after a meal. Am J Gastroenterol. 1994;89(7):992–1002. Available at: https://pubmed.ncbi.nlm.nih.gov/8017397/.https://pubmed.ncbi.nlm.nih.gov/8017397/
Person E., Rife C., Freeman J., Clark A., Castell D.O. A Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: a Randomized Controlled Trial. J Clin Gastroenterol. 2015;49(8):655–659. https://doi.org/10.1097/MCG.0000000000000359..
DOI: 10.1097/MCG.0000000000000359
Khan B.A., Sodhi J.S., Zargar S.A., Javid G., Yattoo G.N., Shah A. et al. Effect of bed head elevation during sleep in symptomatic patients of nocturnal gastroesophageal reflux. J Gastroenterol Hepatol. 2012;27(6):1078–1082. https://doi.org/10.1111/j.1440-1746.2011.06968.x..
DOI: 10.1111/j.1440-1746.2011.06968.x
Kessing B.F., Bredenoord A.J., Saleh C.M.G., Smout A.J.P.M. Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2015;13(6):1089–1095. https://doi.org/10.1016/j.cgh.2014.11.034..
DOI: 10.1016/j.cgh.2014.11.034
Herregods T.V.K., Bredenoord A.J., Smout A.J.P.M. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastro enterol Motil. 2015;27(9):1202–1213. https://doi.org/10.1111/nmo.12611..
DOI: 10.1111/nmo.12611
Patel A., Yadlapati R. Diagnosis and Management of Refractory Gastroesophageal Reflux Disease. Gastroenterol Hepatol (N Y). 2021;17(7):305–315. Available at: https://pubmed.ncbi.nlm.nih.gov/34602892/.https://pubmed.ncbi.nlm.nih.gov/34602892/
Patel A., Yadlapati R. Diagnosis and Management of Refractory Gastroesophageal Reflux Disease. Gastroenterol Hepatol (N Y). 2021;17(7):305–315. Available at: https://pubmed.ncbi.nlm.nih.gov/34602892/.https://pubmed.ncbi.nlm.nih.gov/34602892/
Katz P.O., Gerson L.B., Vela M.F. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–328. https://doi.org/10.1038/ajg.2012.444..
DOI: 10.1038/ajg.2012.444
Gyawali C.P., Kahrilas P.J., Savarino E., Zerbib F., Mion F., Smout A.J.P.M. et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351–1362. https://doi.org/10.1136/gutjnl-2017-314722..
DOI: 10.1136/gutjnl-2017-314722
Savarino E., Pohl D., Zentilin P., Dulbecco P., Sammito G., Sconfienza L. et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009;58(9):1185–1191. https://doi.org/10.1136/gut.2008.175810..
DOI: 10.1136/gut.2008.175810
Poh C.H., Gasiorowska A., Navarro-Rodriguez T., Willis M.R., Hargadon D., Noelck N. et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71(1):28–34. https://doi.org/10.1016/j.gie.2009.08.024..
DOI: 10.1016/j.gie.2009.08.024
Rex D.K., Cummings O.W., Shaw M., Cumings M.D., Wong R.K., Vasudeva R.S. et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125(6):1670–1677. https://doi.org/10.1053/j.gastro.2003.09.030..
DOI: 10.1053/j.gastro.2003.09.030
Johansson J., Håkansson H.-O., Mellblom L., Kempas A., Johansson K.-E., Granath F., Nyrén O. Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction. Scand J Gastroenterol. 2005;40(8):893–902. https://doi.org/10.1080/00365520510015692..
DOI: 10.1080/00365520510015692
Johansson J., Håkansson H.-O., Mellblom L., Kempas A., Johansson K.-E., Granath F., Nyrén O. Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction. Scand J Gastroenterol. 2005;40(8):893–902. https://doi.org/10.1080/00365520510015692..
DOI: 10.1080/003655205 10015692
Sharma P. Review article: prevalence of Barrett’s oesophagus and metaplasia at the gastro-oesophageal junction. Aliment Pharmacol Ther. 2004;20(Suppl. 5):48–54. https://doi.org/10.1111/j.1365-2036.2004.02138.x..
DOI: 10.1111/j.1365-2036.2004.02138.x
Dent J., Becher A., Sung J., Zou D., Agréus L., Bazzoli F. Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys. Clin Gastroenterol Hepatol. 2012;10(8):863–873.e3. https://doi.org/10.1016/j.cgh.2012.02.028..
DOI: 10.1016/j.cgh.2012.02.028
Yamasaki T., Fass R. Reflux hypersensitivity: a new functional esophageal disorder. J Neurogastroenterol Motil. 2017;23:495–503. https://doi.org/10.5056/jnm17097..
DOI: 10.5056/jnm17097
Fass R., Zerbib F., Gyawali C.P. AGA Clinical Practice Update on Functional Heartburn: Expert Review. Gastroenterology. 2020;158(8):2286–2293. https://doi.org/10.1053/j.gastro.2020.01.034..
DOI: 10.1053/j.gastro.2020.01.034
Маев И.В., Баркалова Е.В., Кучерявый Ю.А., Овсепян М.А., Андреев Д.Н., Мовтаева П.Р., Шабуров Р.И. Паттерны эзофагеальной ацидификации и нарушений моторики при заболеваниях пищевода. Вестник Российской академии медицинских наук. 2020;75(2):96–105. https://doi.org/10.15690/vramn1211..
DOI: 10.15690/vramn1211
Маев И.В., Баркалова Е.В., Овсепян М.А., Кучерявый Ю.А., Андреев Д.Н. Возможности рН-импедансометрии и манометрии высокого разрешения при ведении пациентов с рефрактерной гастроэзофагеальной рефлюксной болезнью. Терапевтический архив. 2017;89(2):76–83. https://doi.org/10.17116/terarkh201789276-83..
DOI: 10.17116/terarkh201789276-83
Martinez S.D., Malagon I.B., Garewal H.S., Cui H., Fass R. Non-erosive reflux disease (NERD) – acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17(4):537–545. https://doi.org/10.1046/j.1365-2036.2003.01423.x..
DOI: 10.1046/j.1365-2036.2003.01423.x
Savarino V., Marabotto E., Zentilin P., Demarzo M.G., Pellegatta G., Frazzoni M. et al. Esophageal reflux hypersensitivity: Non-GERD or still GERD? Dig Liver Dis. 2020;52(12):1413–1420. https://doi.org/10.1016/j.dld.2020.10.003..
DOI: 10.1016/j.dld.2020.10.003
Aziz Q., Fass R., Gyawali C.P., Miwa H., Pandolfino J.E., Zerbib F. Esophageal Disorders. Gastroenterology. 2016;150(6):1368–1379. https://doi.org/10.1053/j.gastro.2016.02.012..
DOI: 10.1053/j.gastro.2016.02.012
Aggarwal P., Kamal A.N. Reflux Hypersensitivity: How to Approach Diagnosis and Management. Curr Gastroenterol Rep. 2020;22(9):42. https://doi.org/10.1007/s11894-020-00779-x..
DOI: 10.1007/s11894-020-00779-x
Savarino E., Zentilin P., Tutuian R., Pohl D., Gemignani L., Malesci A., Savarino V. Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. J Gastroenterol. 2012;47(2):159–168. https://doi.org/10.1007/s00535-011-0480-0..
DOI: 10.1007/s00535-011-0480-0
Spechler S.J., Hunter J.G., Jones K.M., Lee R., Smith B.R., Mashimo H. et al. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. N Engl J Med. 2019;381(16):1513–1523. https://doi.org/10.1056/NEJMoa1811424..
DOI: 10.1056/NEJMoa1811424
Ивашкин В.Т., Маев И.В., Трухманов А.С., Сторонова О.А., Кучерявый Ю.А., Баркалова Е.В. и др. Манометрия высокого разрешения и новая классификация нарушений моторики пищевода. Терапевтический архив. 2018;(5):93–99. Режим доступа: https://cyberleninka.ru/article/n/manometriya-vysokogo-razresheniya-i-novaya-klassifikatsiya-narusheniy-motoriki-pischevoda/viewer.https://cyberleninka.ru/article/n/manometriya-vysokogo-razresheniya-i-novaya-klassifikatsiya-narusheniy-motoriki-pischevoda/viewer
Ивашкин В.Т., Маев И.В., Трухманов А.С., Сторонова О.А., Кучерявый Ю.А., Баркалова Е.В. и др. Манометрия высокого разрешения и новая классификация нарушений моторики пищевода. Терапевтический архив. 2018;(5):93–99. Режим доступа: https://cyberleninka.ru/article/n/manometriya-vysokogo-razresheniya-i-novaya-klassifikatsiya-narusheniy-motoriki-pischevoda/viewer.https://cyberleninka.ru/article/n/manometriya-vysokogo-razresheniya-i-novaya-klassifikatsiya-narusheniy-motoriki-pischevoda/viewer
Ивашкин В.Т., Маев И.В., Трухманов А.С. Сторонова О.А., Абдулхаков С.Р., Андреев Д.Н. и др. Рекомендации Российской гастроэнтерологической ассоциации по клиническому применению манометрии высокого разрешения при заболеваниях пищевода. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020;30(3):61–88. https://doi.org/10.22416/1382-4376-2020-30-3-61-88..
DOI: 10.22416/1382-4376-2020-30-3-61-88
Fisichella P.M., Andolfi C., Orthopoulos G. Evaluation of Gastroesophageal Reflux Disease. World J Surg. 2017;41(7):1672–1677. https://doi.org/10.1007/s00268-017-3953-3..
DOI: 10.1007/s00268-017-3953-3
Маев И.В., Бусарова Г.А., Андреев Д.Н. Болезни пищевода. М.: ГЭОТАР-Медиа; 2019. 37 с. Режим доступа: https://medknigaservis.ru/wp-content/uploads/2019/01/NF0012672.pdf.https://medknigaservis.ru/wp-content/uploads/2019/01/NF0012672.pdf
Маев И.В., Бусарова Г.А., Андреев Д.Н. Болезни пищевода. М.: ГЭОТАР-Медиа; 2019. 37 с. Режим доступа: https://medknigaservis.ru/wp-content/uploads/2019/01/NF0012672.pdf.https://medknigaservis.ru/wp-content/uploads/2019/01/NF0012672.pdf
Маев И.В., Юренев Г.Л., Вьючнова Е.С., Андреев Д.Н., Дичева Д.Т., Парцваниа-Виноградова Е.В. Гастроэзофагеальная рефлюксная болезнь. М.: ГЭОТАР-Медиа; 2019. 80 с.
Маев И.В., Дичева Д.Т., Андреев Д.Н. Подходы к индивидуализации лечения гастроэзофагеальной рефлюксной болезни. Эффективная фармакотерапия. 2012;(4):18–22. Режим доступа: https://www.gastroscan.ru/literature/authors/6449.https://www.gastroscan.ru/literature/authors/6449
Маев И.В., Дичева Д.Т., Андреев Д.Н. Подходы к индивидуализации лечения гастроэзофагеальной рефлюксной болезни. Эффективная фармакотерапия. 2012;(4):18–22. Режим доступа: https://www.gastroscan.ru/literature/authors/6449.https://www.gastroscan.ru/literature/authors/6449
Iwakiri K., Kinoshita Y., Habu Y., Oshima T., Manabe N., Fujiwara Y. et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016;51(8):751–767. https://doi.org/10.1007/s00535-016-1227-8..
DOI: 10.1007/s00535-016-1227-8
Hunt R., Armstrong D., Katelaris P., Afihene M., Bane A., Bhatia S. et al. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017;51(6):467–478. https://doi.org/10.1097/MCG.0000000000000854..
DOI: 10.1097/MCG.0000000000000854
Katz P.O., Dunbar K.B., Schnoll-Sussman F.H., Greer K.B., Yadlapati R., Spechler S.J. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117(1):27–56. https://doi.org/10.14309/ajg.0000000000001538..
DOI: 10.14309/ajg.0000000000001538
Akiyama J., Kuribayashi S., Baeg M.K., de Bortoli N., Valitova E, Savarino E.V. et al. Current and future perspectives in the management of gastroesophageal reflux disease. Ann N Y Acad Sci. 2018;1434(1):70–83. https://doi.org/10.1111/nyas.13850..
DOI: 10.1111/nyas.13850
Маев И.В., Андреев Д.Н., Гончаренко А.Ю., Дичева Д.Т. Ингибиторы протонной помпы как основа лечения кислотозависимых заболеваний. Справочник поликлинического врача. 2013;(7–8):42–44. Режим доступа: https://www.gastroscan.ru/literature/authors/7083.https://www.gastroscan.ru/literature/authors/7083
Маев И.В., Андреев Д.Н., Гончаренко А.Ю., Дичева Д.Т. Ингибиторы протонной помпы как основа лечения кислотозависимых заболеваний. Справочник поликлинического врача. 2013;(7–8):42–44. Режим доступа: https://www.gastroscan.ru/literature/authors/7083.https://www.gastroscan.ru/literature/authors/7083
Маев И.В., Андреев Д.Н., Кучерявый Ю.А. Фармакотерапия заболеваний верхних отделов желудочнокишечного тракта. М.: Ремедиум; 2021. 112 с.
Chen Y., Sun C., Wu Y., Chen X., Kailas S., Karadsheh Z. et al. Do proton pump inhibitors prevent Barrett’s esophagus progression to high-grade dysplasia and esophageal adenocarcinoma? An updated meta-analysis. J Cancer Res Clin Oncol. 2021;147(9):2681–2691. https://doi.org/10.1007/s00432-021-03544-3..
DOI: 10.1007/s00432-021-03544-3
Bor S., Kalkan İ.H., Çelebi A., Dinçer D., Akyüz F., Dettmar P., Özen H. Alginates: From the ocean to gastroesophageal reflux disease treatment. Turk J Gastroenterol. 2019;30(Suppl. 2):109–136. https://doi.org/10.5152/tjg.2019.19677..
DOI: 10.5152/tjg.2019.19677
Маев И.В., Дичева Д.Т., Андреев Д.Н., Биткова Е.Н. Место альгинатов в современных алгоритмах терапии гастроэзофагеальной рефлюксной болезни. Consilium Medicum. Гастроэнтерология (Прил.) 2012;(2):12–17. Режим доступа: https://www.gastroscan.ru/literature/authors/6459.https://www.gastroscan.ru/literature/authors/6459
Маев И.В., Дичева Д.Т., Андреев Д.Н., Биткова Е.Н. Место альгинатов в современных алгоритмах терапии гастроэзофагеальной рефлюксной болезни. Consilium Medicum. Гастроэнтерология (Прил.) 2012;(2):12–17. Режим доступа: https://www.gastroscan.ru/literature/authors/6459.https://www.gastroscan.ru/literature/authors/6459
Mandel K.G., Daggy B.P., Brodie D.A., Jacoby H.I. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment Pharmacol Ther. 2000;14(6):669–690. https://doi.org/10.1046/j.1365-2036.2000.00759.x..
DOI: 10.1046/j.1365-2036.2000.00759.x
Strugala V., Avis J., Jolliffe I.G., Johnstone L.M., Dettmar P.W. The role of an alginate suspension on pepsin and bile acids – key aggressors in the gastric refluxate. Does this have implications for the treatment of gastrooesophageal reflux disease? J Pharm Pharmacol. 2009;61(8):1021–1028. https://doi.org/10.1211/jpp/61.08.0005..
DOI: 10.1211/jpp/61.08.0005
Tran T., Lowry A.M., El-Serag H.B. Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther. 2007;25(2):143–153. https://doi.org/10.1111/j.1365-2036.2006.03135.x..
DOI: 10.1111/j.1365-2036.2006.03135.x
Leiman D.A., Riff B.P., Morgan S., Metz D.C., Falk G.W., French B. et al. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis Esophagus. 2017;30(5):1–9. https://doi.org/10.1093/dote/dow020..
DOI: 10.1093/dote/dow020
Huestis M.J., Keefe K.R., Kahn C.I., Tracy L.F., Levi J.R. Alternatives to Acid Suppression Treatment for Laryngopharyngeal Reflux. Ann Otol Rhinol Laryngol. 2020;129(10):1030–1039. https://doi.org/10.1177/0003489420922870..
DOI: 10.1177/0003489420922870